Quick Summary
Covering the latest research from top Wall Street investment banks

CITIC Securities Q2 net profit rose 83% YoY; UBS maintains Buy and HK$39.00 target price

Institution
UBS Securities Asia Limited
Date
20260821
Authors
Dennis Bai, Wen Chen, CPA
Company
CITIC Securities H Shares
Ticker
6030.HK
Industry
Diversified Financials (Securities)
Rating
Buy
BullishHigh confidenceReiterateMedium-termUBS believes CITIC Securities achieved broad-based growth across its major businesses and maintains its Buy rating and 12-month target price of HK$39.00.
AuthorsDennis Bai, Wen Chen, CPA
Target priceHK$39.00
CoverageChina、Hong Kong
Business segmentsSecurities Brokerage、Investment Banking、Financing、Asset Management、Investment Management、Overseas Business
Research firm divisions/subsidiariesUBS Securities Asia Limited(Subsidiary/Legal Entity)

AI summary card

CITIC Securities Q2 net profit rose 83% YoY; UBS maintains Buy and HK$39.00 target price

CITIC Securities' revenue and net profit rose 50% and 70% YoY, respectively, in the first half of 2026, while Q2 net profit increased 83% YoY to RMB13.1 billion. UBS believes investment, brokerage, investment banking, asset management, and overseas businesses jointly drove growth and maintains its Buy rating.

Buy|12-month target price HK$39.00|Current price HK$25.86|Forecast price appreciation 50.8%|Forecast stock return 55.4%
CITIC SecuritiesSecurities FirmEarnings GrowthInvestment IncomeSecurities BrokerageInvestment BankingAsset ManagementOverseas Expansion
  • Revenue was RMB49.7 billion and net profit was RMB23.3 billion in the first half of 2026, up 50% and 70% YoY, respectively.
  • Q2 net profit rose 83% YoY to RMB13.1 billion, outperforming the industry average.
  • Q2 net investment income reached a record RMB15.5 billion, up 48% YoY and 30% QoQ.
  • First-half net revenue from brokerage, investment banking, and asset management rose 54%, 44%, and 32% YoY, respectively.
  • Overseas revenue rose 71% YoY, increasing its share of group revenue to 24%.
  • Non-annualized ROE increased 2.9 percentage points YoY to 7.8%.
  • UBS maintains its HK$39.00 target price and Buy rating.

Report interpretation

Overview

This report reviews CITIC Securities' results for the first half and second quarter of 2026. UBS believes the company's growth did not depend on a single business but was jointly contributed by investment, brokerage, investment banking, asset management, financing, and overseas operations. Supported by improving capital-market activity and overseas expansion, UBS maintains its Buy rating and HK$39.00 target price.

Core views

CITIC Securities generated revenue of RMB49.7 billion and net profit of RMB23.3 billion in the first half of 2026, representing YoY growth of 50% and 70%, respectively, in line with its prior profit alert. This implies Q2 net profit rose 83% YoY to RMB13.1 billion, outperforming the industry average and ranking roughly in the middle among leading securities firms. During the same period, average daily A-share turnover, margin financing and securities lending balances, and IPO proceeds rose 1.3 times, 63%, and 1.1 times YoY, respectively, providing a relatively favorable market environment for multiple business segments. First-half non-annualized ROE increased 2.9 percentage points YoY to 7.8%. As of the end of June, UBS estimated that the adjusted leverage ratio increased 0.6 times YoY to approximately 5.1 times. The interim dividend per share was RMB0.43, corresponding to a payout ratio of 29.4%, versus RMB0.29 and 32.5% in the prior-year period. The investment business was the principal growth driver. First-half net investment income rose 41% YoY, implying that Q2 investment profit reached a record RMB15.5 billion, up 48% YoY and 30% QoQ. The equity market rebounded significantly in Q2, with the STAR 50, ChiNext Index, and CSI 300 rising 76%, 36%, and 12%, respectively. By comparison, their respective performances were -2%, 2%, and 1% in Q2 2025 and -7%, -1%, and -4% in Q1 2026. UBS believes CITIC Securities captured the rebound in Chinese technology stocks effectively through strategic co-investments and proprietary positions, while its strong IPO pipeline provides an additional channel for value creation. First-half net brokerage revenue rose 54% YoY, implying Q2 growth of 61% YoY and 1% QoQ. During the same period, average daily A-share equity-related turnover rose 1.3 times YoY and 7.3% QoQ. Brokerage revenue growth did not fully keep pace with trading volume, indicating that commission rates remained under pressure. On the other hand, improving retail risk appetite and market sentiment drove financial product distribution revenue up 91% YoY in the first half and 35% compared with the second half, providing important support for wealth-management-related revenue. First-half net investment banking revenue rose 44% YoY, implying Q2 growth of 62% YoY and 50% QoQ. UBS estimated that CITIC Securities' market shares in A-share IPOs and refinancing increased to 21% and 40%, respectively. During the same period, A-share IPO proceeds increased to RMB45.0 billion, up 1.3 times YoY and 73% QoQ. In Hong Kong, CITIC Securities' IPO market share reached approximately 11% amid total market IPO issuance exceeding HK$100 billion, increasing by approximately 7 and 1 percentage points YoY and QoQ, respectively. As of August 21, 2026, the company had mandates for 54 A-share and 96 H-share IPO projects, indicating that its project pipeline remained ample. First-half net asset management revenue rose 32% YoY, implying Q2 growth of 28% YoY and 5% QoQ. As of the end of June, assets under management under CITIC Securities' proprietary brand increased 27% YoY, faster than the approximately 17% growth of the securities industry. China AMC's assets under management increased approximately 2% YoY, but UBS estimated that its profit margin narrowed by 2 percentage points to approximately 25%, creating relative pressure within the asset management segment. The financing business also benefited from stronger market activity. First-half net interest income increased 6.9 times YoY, implying Q2 growth of 66% YoY. As of the end of June, the company's market share in margin financing and securities lending increased 0.6 percentage points YoY and 0.05 percentage points QoQ to approximately 8.4%, indicating a further strengthening of its market position in financing. The overseas business continued to expand, with first-half overseas revenue rising 71% YoY and 37% compared with the second half, increasing its share of group revenue to 24%, versus approximately 21% in both the first and second halves of 2025. Following the completion of an RMB16.0 billion H-share placement, UBS expects international operations to play an increasingly important role in future growth and profitability. UBS forecasts the company's revenue at RMB93.785 billion, RMB103.898 billion, RMB114.334 billion, RMB127.759 billion, and RMB144.028 billion from 2026 through 2030, respectively; pre-tax profit at RMB52.254 billion, RMB58.997 billion, RMB65.379 billion, RMB73.773 billion, and RMB83.933 billion, respectively; and net profit at RMB40.260 billion, RMB45.527 billion, RMB50.497 billion, RMB57.056 billion, and RMB65.011 billion, respectively. UBS's diluted EPS forecasts for 2026 through 2028 are RMB2.72, RMB3.07, and RMB3.41, respectively, above consensus estimates of RMB2.65, RMB2.88, and RMB3.22 for the same periods. On valuation, UBS uses a dividend discount model to value CITIC Securities' H shares and maintains its 12-month target price of HK$39.00 and Buy rating. Based on the share price of HK$25.86 on August 20, 2026, the report indicates forecast price appreciation of 50.8% and a forecast dividend yield of 4.6%, for a total forecast stock return of 55.4%. Relative to the assumed market return of 11.2%, the forecast excess return is 44.3%. The forecast 2026 price-to-book ratio is 0.9 times. In a short-term quantitative assessment separate from the 12-month rating, UBS assigned scores of 4 to both the industry structure and regulatory environment over the next six months, indicating a bias toward improvement. The company's conditions over the past three to six months also received a score of 4. Both the degree of surprise in the next EPS update relative to consensus and the directional earnings risk relative to UBS's own forecast received scores of 3, indicating expectations broadly in line with consensus and relatively balanced upside and downside risks.

Analysis framework

UBS first reconciles the company's disclosed figures and profit alert with first-half total revenue, net profit, and implied Q2 performance, then breaks down the sources of growth across investment, brokerage, investment banking, asset management, net interest income, and overseas operations. The analysis cross-compares revenue changes in each business with operating indicators such as A-share turnover, margin financing and securities lending, IPO proceeds, equity index performance, market share, and assets under management, while using UBS estimates and Wind pipeline data to assess growth quality and subsequent support. Finally, the report combines earnings forecasts with a dividend discount model to derive the 12-month target price and supplements its views on the industry, regulation, and earnings expectations with a short-term quantitative questionnaire.

Methodology notes

  • Valuation MethodDDM Dividend Discount

    Dividend Discount Model (DDM)

    This method discounts expected future dividends to their present value. UBS uses it to value CITIC Securities' H shares and accordingly maintains its 12-month target price of HK$39.00.

  • Industry/Sector Analysis FrameworkVolume-price decomposition

    Comparison of growth by business with market activity indicators

    The report compares brokerage, investment banking, investment, asset management, and financing revenue with turnover, IPO proceeds, equity index performance, assets under management, and margin financing and securities lending market share to determine whether growth stems from market expansion, market-share gains, or fee-rate changes.

  • Quantitative/Factor/Portfolio Theory

    Forecast Stock Return (FSR)

    The report adds the expected price appreciation over the next 12 months to the total dividend yield to calculate the forecast stock return and then compares it with the assumed market return. In this report, the forecast stock return is 55.4%, the assumed market return is 11.2%, and the forecast excess return is 44.3%.

  • Quantitative/Factor/Portfolio Theory

    Quantitative Research Review short-term factor scores

    UBS uses a 1-to-5 questionnaire to assess the industry and regulatory environment over the next six months, recent company trends, and expectation gaps and directional risks for the next earnings update. This short-term assessment uses a different time horizon from the report's 12-month stock rating.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • CITIC Securities H Shares (6030.HK)
    The report believes the company benefits from recovering activity in China's capital markets, the IPO recovery, increased margin financing and securities lending market share, and overseas business expansion.
    Strengths
    It is China's largest securities company by total assets, with its major businesses consistently ranking among the industry's top five. Investment, brokerage, investment banking, asset management, financing, and overseas operations all achieved growth during the period, and the company has strong A-share and H-share IPO pipelines.
    Weaknesses
    Brokerage revenue growth lagged the increase in market turnover, reflecting continued pressure on commission rates. China AMC's profit margin narrowed by approximately 2 percentage points to approximately 25%.
    Comparison
    Q2 net profit growth outperformed the industry average and ranked roughly in the middle among leading securities firms. Proprietary-brand assets under management grew 27%, faster than the securities industry's approximately 17% growth.
    Risks
    Earnings and valuation are relatively sensitive to changes in equity-market turnover, investor sentiment, capital-market activity, asset prices, and the regulatory environment.

Key data

  • First-half 2026 revenueRMB49.7 billionUp 50% YoY and in line with the prior profit alert.
  • First-half 2026 net profitRMB23.3 billionUp 70% YoY.
  • Implied Q2 net profitRMB13.1 billionUp 83% YoY, outperforming the industry average.
  • First-half non-annualized ROE7.8%Up 2.9 percentage points YoY.
  • Adjusted leverage ratioApproximately 5.1 timesAs of the end of June 2026, UBS estimated an increase of 0.6 times YoY.
  • Interim dividend per share and payout ratioRMB0.43 / 29.4%RMB0.29 / 32.5% in the first half of 2025.
  • Q2 investment profitRMB15.5 billionA record high, up 48% YoY and 30% QoQ.
  • First-half net revenue growth by businessBrokerage +54%, investment banking +44%, asset management +32%Indicates that earnings growth spanned multiple core businesses.
  • A-share IPO and refinancing market shares21% / 40%UBS estimated that the company continued to gain market share in both businesses.
  • A-share and H-share IPO pipeline54 / 96 projectsAs of August 21, 2026; data sourced from Wind.
  • Growth in proprietary-brand assets under management27%YoY growth as of the end of June, above the securities industry's approximately 17%.
  • Margin financing and securities lending market shareApproximately 8.4%As of the end of June, up 0.6 percentage points YoY and 0.05 percentage points QoQ.
  • Overseas revenue growth and contribution+71% YoY / 24% of group revenueThe contribution increased from approximately 21% in both the first and second halves of 2025.
  • UBS diluted EPS forecasts for 2026 through 2028RMB2.72 / 3.07 / 3.41Consensus estimates for the same periods are RMB2.65 / 2.88 / 3.22.
  • 12-month target priceHK$39.00Based on the dividend discount model; Buy rating maintained.
  • Forecast stock return55.4%Includes forecast price appreciation of 50.8% and a forecast dividend yield of 4.6%.

Impact & implications

The report believes CITIC Securities' earnings improvement is broadly based: the market rebound directly boosted investment income and brokerage activity, the IPO recovery and market-share gains drove investment banking revenue, improving retail risk appetite supported product distribution, a higher margin financing and securities lending market share enhanced net interest income, and the rising contribution from overseas operations expanded new sources of earnings. UBS also notes that pressure on brokerage commission rates and the narrowing of China AMC's profit margin mean that growth in trading volume and scale will not translate fully into equivalent revenue or profit growth. Nevertheless, the strong IPO pipeline, international expansion following the RMB16.0 billion H-share placement, and UBS's above-consensus EPS forecasts for 2026 through 2028 collectively support its Buy rating and target-price assessment.

Risks

  • Chinese securities firms' earnings have high leverage to equity-market conditions. Brokerage revenue depends directly on market turnover, while investment banking, wealth management, and financing businesses are also affected by investor sentiment and capital-market activity.
  • Market volatility may alter the valuation of financial assets and further affect the company's book value.
  • China's equity market is jointly influenced by market and regulatory factors, and changes in either could increase uncertainty around earnings and valuation.

What to watch

  • Monitor A-share turnover, margin financing and securities lending activity, and pressure on commission rates, as trading-volume growth has not yet translated fully into brokerage revenue growth.
  • Monitor A-share and Hong Kong IPO proceeds, the company's IPO market share, and the conversion of its pipeline of 54 A-share and 96 H-share projects.
  • Monitor growth in proprietary-brand assets under management, China AMC's assets under management, and changes in its approximately 25% profit margin.
  • Monitor whether overseas revenue can continue to increase from its 24% share of group revenue and the expansion of international operations following the RMB16.0 billion H-share placement.
  • Monitor changes in the equity market and regulatory environment; UBS's short-term quantitative assessment assigned both factors a score of 4 for the next six months.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins